As of 2024-12-12, the Intrinsic Value of Advanced Oncotherapy PLC (AVO.L) is
-37.88 GBP. This AVO.L valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.93 GBP, the upside of Advanced Oncotherapy PLC is
-2,067.79%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-37.88 GBP
Intrinsic Value
AVO.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-37.88 - -37.88 |
-37.88 |
-2,067.79% |
| P/E |
(128.03) - (143.19) |
(131.44) |
-6928.2% |
| DDM - Stable |
(81.18) - 3,746.20 |
1,832.51 |
95095.4% |
| DDM - Multi |
(0.95) - 33.71 |
(1.94) |
-200.9% |
AVO.L Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
10.41 |
| Beta |
0.23 |
| Outstanding shares (mil) |
5.41 |
| Enterprise Value (mil) |
67.64 |
| Market risk premium |
5.98% |
| Cost of Equity |
7.18% |
| Cost of Debt |
5.00% |
| WACC |
5.23% |